American Stock Exchange Lists the Common Stock of Xcorporeal, Inc.

Dec 07, 2007, 00:00 ET from American Stock Exchange

    NEW YORK, Dec. 7 /PRNewswire/ -- The American Stock Exchange(R)
 (Amex(R)) today lists the common stock of Xcorporeal, Inc. under the ticker
 symbol XCR.
     Xcorporeal, Inc. is a medical device company developing an innovative
 extra-corporeal platform technology that may be used in devices to replace
 the function of various human organs. The platform will lead to three
 initial products; a device for home hemodialysis, another device for
 hospital Renal Replacement Therapy (RRT) and the Wearable Artificial Kidney
 (WAK) for continuous ambulatory hemodialysis. These devices will seek to
 provide patients with improved, efficient and cost effective therapy. The
 RRT markets represent multibillion dollar opportunities.
     "We are pleased to welcome Xcorporeal, Inc. to the American Stock
 Exchange," said Neal Wolkoff, Chairman and CEO of Amex. "We look forward to
 working with Xcorporeal and building strong relationships within the
 investment community to enhance their growth in the marketplace."
     The specialist for Xcorporeal, Inc. is Cohen Specialist LLC. For
 further information on XCR and other Amex-listed companies, please visit
     About American Stock Exchange
     The American Stock Exchange(R) (Amex(R)) offers trading across a full
 range of equities, options and exchange traded funds (ETFs), including
 structured products and HOLDRS(SM). In addition to its role as a national
 equities market, the Amex is the pioneer of the ETF, responsible for
 bringing the first domestic product to market in 1993. Leading the industry
 in ETF listings, the Amex lists 379 ETFs to date. The Amex is also one of
 the largest options exchanges in the U.S., trading options on broad-based
 and sector indexes as well as domestic and foreign stocks. For more
 information, please visit

SOURCE American Stock Exchange